Source: Research Seminar 2005 - Adaptations to Hypoxia



Rating:

Share or cite this content

Citations should be made in the following way:
M. Bonsignore (Palermo, Italy). Hypoxia and the bone marrow. Research Seminar 2005 - Adaptations to Hypoxia

Member's Comments

No comment yet.

Related content which might interest you: Bone marrow progenitor cells in patients with COPD Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010 Lung transplantation after bone marrow transplantationin paediatric patients Source: Eur Respir J 2006; 28: Suppl. 50, 725s Year: 2006 The contribution of bone marrow derived progenitor cells to lung remodelling Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling Year: 2008 Pulmonary hypertension after bone marrow transplantation in children Source: Eur Respir J, 54 (5) 1900612; 10.1183/13993003.00612-2019 Year: 2019 Monitoring of lung function and airways inflammation after bone marrow transplantation Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008 Phenotypical and molecular characteristics of bone marrow mesenchymal stem cells in rheumatoid lung Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury Source: Eur Respir J 2009; 34: 740 Year: 2009 Bone marrow derived mesenchymal stem cells accelerate alveolar epithelial repair in vitro Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly? Year: 2007 Bone marrow characteristics in patients with COPD and eosinophilia Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Investigation of the participation of bone marrow derived cells in pulmonary angiogenesis and vascular remodeling Source: Eur Respir J 2002; 20: Suppl. 38, 481s Year: 2002 Beneficial effects of autologous bone marrow mononuclear cell transplantation via the trachea against elastase-induced emphysema in rabbits Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008 Imatinib inhibits bone marrow-derived c-kit+ cell mobilisation in hypoxic pulmonary hypertension Source: Eur Respir J 2010; 36: 1209-1211 Year: 2010 Functional characterisation of bone marrow-derived mesenchymal stromal cells from COPD patients Source: ERJ Open Res 2016: 00045-2015 Year: 2016 Effects of bone marrow mononuclear cell therapy in an experimental model of silicosis Source: Annual Congress 2008 - Respiratory pathophysiology from cell and animal research Year: 2008 Electroporation of Hepatocyte growth factor to the lung induces migration of bone marrow mesenchymal stem cells and reduces lung fibrosis Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Lung function 5 yrs after allogeneic bone marrow transplantation conditioned with busulphan and cyclophosphamide Source: Eur Respir J 2004; 23: 901-905 Year: 2004 HGF expressing stem cells in the human fibrotic lung originate from the bone marrow Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both? Year: 2011 Bone marrow-derived mononuclear cell therapy reduces lung and distal organ damage in severe sepsis Source: Annual Congress 2010 - Acute lung injury and ventilator-induced lung injury Year: 2010 Impaired migration of bone marrow mesenchymal stem cells in COPD Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013